Factors Associated with Dose Modification of Lenalidomide Plus Dexamethasone Therapy in Multiple Myeloma.
Kado Y, Tsujimoto M, Fuchida SI, Okano A, Hatsuse M, Murakami S, Sugii H, Ueda K, Toda Y, Minegaki T, Nishiguchi K, Muraki Y, Shimazaki C, Ashihara E.
Kado Y, et al. Among authors: fuchida si.
Biol Pharm Bull. 2020;43(8):1253-1258. doi: 10.1248/bpb.b20-00337.
Biol Pharm Bull. 2020.
PMID: 32741946
Free article.